The Maryland Dermatologic Society cordially invites you to attend a CME activity that aims to improve learners’ knowledge, confidence, and competence in effectively using immune checkpoint inhibitors to improve outcomes in patients with basal cell carcinoma and cutaneous squamous cell carcinoma.
Justine V. Cohen, D.O., is a medical oncologist at the Center for Cancer Therapeutic Innovation (Early Drug Development Program). She is a Senior Physician at the Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School specializing in immunotherapy and targeted therapy for melanoma and cutaneous cancers.
AMA PRA Category 1 Credit™, ABIM MOC, ANCC, AAPA, and ACPE- certified live webinar titled, “Immune Checkpoint Inhibitors in BCC and CSCC: Aligning Clinical Practice With Best Practices and Guidelines.”